Puma Biotech Sinks On Cancer Drug Filing Delay
Biotechnology News
Puma Biotechnology said Tuesday that it won't file for marketing approval of an experimental breast cancer drug until early 2016, sending its shares plunging in aftermarket trading. The company had said ...
Source